Infection Prevention and Sepsis Recognition in Home Care

When:  Feb 29, 2024 from 02:00 PM to 03:00 PM (ET)

Date: February 29, 2024

Time: 2:00 - 3:00 pm ET / 11:00 am - 12:00 pm PT

Patients and caregivers play a pivotal role in infection prevention in home care settings. Infusions administered in a home-based setting receive less frequent monitoring by a healthcare professional than those administered in a hospital, putting patients at an increased risk of sepsis and other complications due to infection. 
In this comprehensive presentation, the presenter will discuss the intricacies of home care, focusing on the distinct roles of patients, caregivers, and healthcare workers in home care. The various types of infections that may arise in a home care setting will be explored, as well as proactive measures to ensure a safe and conducive home care environment. Additionally, the session will provide a review of patient education tools, patient video, and “train the trainer” video available to participants for use and education of their staff, patients, and caregivers. Participants will obtain a comprehensive understanding of home care responsibilities, infection management, and the nuanced approach required to maintain a safe and effective care environment.

Learning Objectives: 

At the end of the activity, the learner should be able to:

  • Identify the responsibilities of patients, caregivers, and healthcare workers in home care;
  • Describe types of infections that may occur in home care;
  • Explain the role of patients and caregivers in infection prevention in home care;
  • List warning signs of sepsis in home care;
  • Describe how to balance prevention of antibiotic resistance with management of sepsis in home care.

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.


Funding for this program was provided in part by an independent educational grant from Pfizer, Inc.